Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Breast Cancer × Fulvestrant × Clear all

Phase

Status

Unknown 5 Completed 5 Recruiting 3 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 34 Neoplasm Metastasis 5 Ovarian Neoplasms 3 Neoplasms 3 Hereditary Sensory and Autonomic Neuropathies 3 Endometrial Neoplasms 2 Breast Cancer Metastatic 2 Stomach Neoplasms 1 Lymphoma, Non-Hodgkin 1 Hyperglycemia 1 HER2-positive Breast Cancer 1 Carcinosarcoma 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Breast Neoplasms, Male 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Breast Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

olaparib 1 abemaciclib 1 Trastuzumab 1 Letrozole 1 Goserelin 1 Fulvestrant 1 Aromatase Inhibitors 1 Anastrozole 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04862143 2024-06-20

TELEPIK

Novartis

Phase 2 Terminated

2 enrolled 10 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡